Literature DB >> 23663130

Results of the CAPPS: COPD--assessment of practice in primary care study.

Daniel Belletti1, Jia Liu, Christopher Zacker, Jenifer Wogen.   

Abstract

OBJECTIVE: Since many patients with COPD in the US are managed by primary care physicians, we evaluated adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in a primary care setting.
METHODS: A cross-sectional study was conducted using a random sample of patients (n=50-150 per site) aged 40-89 years with diagnosed COPD. Patients were identified for study inclusion (N=1517) from 11 US primary care sites. Demographic and clinical information was extracted from primary care medical records via retrospective chart review. The main outcome measures were adherence to GOLD primary care guidelines, assessed via three components as follows: 1. Is there a current diagnostic spirometry test measurement available within the patient's medical record during the prior calendar year? 2. Are comorbid conditions, if present, being treated appropriately? 3. Are adequate risk reduction measures being taken?
RESULTS: Mean patient age was 67.2 (SD±11.3) years, 54% were female, and 34% were current smokers. Overall, 19% of patients had comorbid asthma, 66% hypertension, 61% dyslipidemia, 30% cardiovascular disease, and 28% diabetes. Mean duration of COPD was approximately 4.8 years. Only 27% of patients had a spirometry test result documented within the past year. More than half (52%) of patients did not have a documented COPD stage; 20% were classified as stage I, 13% stage II, 12% stage III, 3% stage IV. About 63% of patients met at least one guideline component, while only 3% of patients met all components; 27% met diagnostic, 25% comorbid conditions management, and 32% met risk reduction criteria. LIMITATIONS: The retrospective design of our study did not allow evaluation of some possible covariates or causal assessment, and spirometry measurements were unavailable for many patients.
CONCLUSIONS: Results suggest that treatment per COPD primary care guidelines was not consistently applied among participating practices (range 0.0%-8.7% for meeting all three components). Educational initiatives may increase primary care providers' knowledge of and adherence to COPD treatment guidelines and recommended patient management strategies.

Entities:  

Mesh:

Year:  2013        PMID: 23663130     DOI: 10.1185/03007995.2013.803957

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Adherence to COPD management guidelines in general practice? A review of the literature.

Authors:  J Sehl; J O'Doherty; R O'Connor; B O'Sullivan; A O'Regan
Journal:  Ir J Med Sci       Date:  2017-07-22       Impact factor: 1.568

2.  On the Use of Sampling Weights for Retrospective Medical Record Reviews.

Authors:  Ernest Shen
Journal:  Perm J       Date:  2020

Review 3.  Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions.

Authors:  Jeff D Overington; Yao C Huang; Michael J Abramson; Juliet L Brown; John R Goddard; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

Review 4.  Overtesting and undertesting in primary care: a systematic review and meta-analysis.

Authors:  Jack W O'Sullivan; Ali Albasri; Brian D Nicholson; Rafael Perera; Jeffrey K Aronson; Nia Roberts; Carl Heneghan
Journal:  BMJ Open       Date:  2018-02-11       Impact factor: 2.692

5.  Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?

Authors:  Fernando J Martinez; Byron Thomashow; Tamar Sapir; Laura Simone; Jeffrey Carter; MeiLan Han
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

6.  Physician-Patient Concordance in Pharmacological Management of Patients with COPD.

Authors:  Mark Small; Victoria Higgins; Adam Lees; Nicola Johns; Anthony Mastrangelo; Tara Nazareth; Stuart J Turner
Journal:  COPD       Date:  2015       Impact factor: 2.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.